Brolucizumab for Diabetic Macular Edema in Participants with/without prior Anti-VEGF Exposure
Ophthalmology Retina · 2026
DOI: 10.1016/j.oret.2025.10.013 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Ophthalmology Retina, 2026. Verfasst von Michael Ip und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles, California; Doheny Eye Institute, Los Angeles, C…. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Macular Edema, Recombinant Fusion Proteins, Visual Acuity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novartis.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles, California; Doheny Eye Institute, Los Angeles, California. Electronic address: MIp@doheny.org.
- Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
- Beijing Novartis Pharma Co., Ltd., Beijing, China.
- Novartis Pharma AG, Basel, Switzerland.
- Medical Center Ophthalmology Associates, San Antonio, Texas.
Förderung
- Novartis
Zitieren
APA
Ip, M., Chaudhary, V., He, F., Bouillaud, E., Kim, Y., Igwe, F., & Singer, M. (2026). Brolucizumab for Diabetic Macular Edema in Participants with/without prior Anti-VEGF Exposure. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2025.10.013
Vancouver
Ip M, Chaudhary V, He F, Bouillaud E, Kim Y, Igwe F, et al. Brolucizumab for Diabetic Macular Edema in Participants with/without prior Anti-VEGF Exposure. Ophthalmology Retina. 2026. doi:10.1016/j.oret.2025.10.013
BibTeX
@article{Ip2026,
author = {Ip, Michael and Chaudhary, Varun and He, Fanyin and Bouillaud, Emmanuel and Kim, Yongsoo and Igwe, Franklin and Singer, Michael},
title = {Brolucizumab for Diabetic Macular Edema in Participants with/without prior Anti-VEGF Exposure},
journal = {Ophthalmology Retina},
year = {2026},
doi = {10.1016/j.oret.2025.10.013}
}
EUVIMED